Is Quizartinib available in the domestic market?

Quizartinib(Quizartinib) is an oral anti-cancer drug that targets FLT3 mutations and is used to treat a specific type of acute myeloid leukemia (AML). Because the drug specifically targets key signaling pathways closely related to disease progression, it is often used as a precision treatment option for specific groups of people in overseas clinical applications. Its advantages are that oral administration is convenient, highly targeted, and can improve disease management strategies in some patients, so it has long attracted attention.

Regarding its accessibility in the Chinese mainland market, currently no domestic origin drug of Quizartinib has been approved for marketing, so it cannot be purchased through hospital channels or ordinary pharmacies. Because it has not been formally approved, there is no clear pricing in the domestic market, resulting in many patients needing to rely on cross-border channels to understand overseas supply. For this type of targeted drugs that have not yet been launched in the country, the price is often affected by various factors such as exchange rates, supply batches, and medical insurance policies of different countries. Therefore, there are usually fluctuations and uncertainties when discussing prices in the country.

In overseas markets, the original drug Quizartinib has been officially launched and can be purchased in common dosages such as 17.7mg (pack of 28 tablets) and 26.5mg (pack of 56 tablets). Affected by changes in the international price system and exchange rates, its overall price is usually in the range of RMB 80,000 to more than RMB 100,000, making it a typical high-cost targeted drug. At the same time, generic versions have also appeared in some overseas countries and regions. The most common ones are generic drugs from Laos and other regions. Their ingredients are the same as the original drugs, but the specifications and number of tablets are different. The price is usually significantly lower than the original drugs. Some package prices are only about 1,000 yuan, which will also fluctuate slightly with the exchange rate. If patients need medication, it is recommended that they communicate with their doctor to evaluate the indications, medication risks and overall treatment plan.

Reference materials:https://go.drugbank.com/drugs/DB12874